Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
About this study
The investigators hypothesize that abnormalities in thromboelastography (TEG) parameters in patients with liver, pancreas, biliary, esophageal, colorectal, and lung adenocarcinoma can serve as biomarkers for oncologic disease burden, cancer recurrence and overall survival as well as thrombotic and hemorrhagic post-operative complications. The investigators further hypothesize that there is histologic pathology correlates to pre-operative TEG abnormalities, and that it identifies patients with virulent tumor biology.
- Condition
- Liver Cancer, Esophageal Cancer, Colorectal Cancer, Lung Adenocarcinoma, Control, Pancreas Cancer, Biliary Cancer
- Tested
- TEG indices
- Sponsor
- University of Colorado, Denver
Who can join
- Age
- 18 to 99 years
- Sex
- All sexes
- Healthy volunteers
- Accepted
Inclusion 5
- Minimum age: 18 years
- Maximum age: 99 years
- Study condition: Liver Cancer, Esophageal Cancer, Colorectal Cancer, Lung Adenocarcinoma, Control, Pancreas Cancer, Biliary Cancer
- new diagnosis by the providing physician of hepatopancreaticobiliary, esophageal, colorectal, lung adenocarcinoma, or liver metastasis of any origin will be eligible for enrollment in the study
- 18 Years and older
Exclusion 5
- Under 18 years old
- prisoners
- unable to provide informed consent
- pregnant women
- and those undergoing emergent or urgent operative intervention at the time of diagnosis
Where
2 sites, 2 recruiting
University of Colorado Denver
Aurora, Colorado, United States
UCHealth Highlands Ranch Hospital
Highlands Ranch, Colorado, United States
Contact
-
Tracey MacDermott, BA BS CCRC
303-724-2757 tracey.macdermott@cuanschutz.edu
-
Ivan Rodriguez, MD
Potential match only. Final eligibility is determined by the study team.